[HTML] thelancet.comFull View

[HTML][HTML] SARS-CoV-2 vaccination in the first year after allogeneic hematopoietic cell transplant: a prospective, multicentre, observational study

JA Hill, MJ Martens, JAH Young, K Bhavsar, J Kou… - …, 2023 - thelancet.com
Background The optimal timing for SARS-CoV-2 vaccines within the first year after
allogeneic hematopoietic cell transplant (HCT) is poorly understood. Methods We conducted …
被引用次数：17 相关文章
[HTML] nih.gov

[HTML][HTML] SARS-CoV-2 vaccination in the first year after allogeneic hematopoietic cell transplant: a prospective, multicentre, observational study

JA Hill, MJ Martens, JAH Young, K Bhavsar… - …, 2023 - ncbi.nlm.nih.gov
Background The optimal timing for SARS-CoV-2 vaccines within the first year after
allogeneic hematopoietic cell transplant (HCT) is poorly understood. Methods We conducted …

SARS-CoV-2 vaccination in the first year after allogeneic hematopoietic cell transplant: a prospective, multicentre, observational study

JA Hill, MJ Martens, JAH Young… - …, 2023 - pubmed.ncbi.nlm.nih.gov
Background The optimal timing for SARS-CoV-2 vaccines within the first year after
allogeneic hematopoietic cell transplant (HCT) is poorly understood. Methods We conducted …

SARS-CoV-2 vaccination in the first year after allogeneic hematopoietic cell transplant: a prospective, multicentre, observational study

JA Hill, MJ Martens, JAH Young, K Bhavsar… - …, 2023 - experts.umn.edu
Background: The optimal timing for SARS-CoV-2 vaccines within the first year after
allogeneic hematopoietic cell transplant (HCT) is poorly understood. Methods: We …

SARS-CoV-2 vaccination in the first year after allogeneic hematopoietic cell transplant: a prospective, multicentre, observational study.

JA Hill, MJ Martens, JAH Young, K Bhavsar, J Kou… - 2023 - cabidigitallibrary.org
Background: The optimal timing for SARS-CoV-2 vaccines within the first year after
allogeneic hematopoietic cell transplant (HCT) is poorly understood. Methods: We …

SARS-CoV-2 vaccination in the first year after allogeneic hematopoietic cell transplant: a prospective, multicentre, observational study

JA Hill, MJ Martens, JAH Young, K Bhavsar… - …, 2023 - profiles.wustl.edu
Background: The optimal timing for SARS-CoV-2 vaccines within the first year after
allogeneic hematopoietic cell transplant (HCT) is poorly understood. Methods: We …

SARS-CoV-2 vaccination in the first year after allogeneic hematopoietic cell transplant: a prospective, multicentre, observational study

J Hill, M Martens, J Young, K Bhavsar, J Kou… - …, 2023 - europepmc.org
Background The optimal timing for SARS-CoV-2 vaccines within the first year after
allogeneic hematopoietic cell transplant (HCT) is poorly understood. Methods We conducted …
[HTML] sciencedirect.com

[HTML][HTML] SARS-CoV-2 vaccination in the first year after allogeneic hematopoietic cell transplant: a prospective, multicentre, observational study

JA Hill, MJ Martens, JAH Young, K Bhavsar, J Kou… - eClinicalMedicine, 2023 - Elsevier
Background The optimal timing for SARS-CoV-2 vaccines within the first year after
allogeneic hematopoietic cell transplant (HCT) is poorly understood. Methods We conducted …

SARS-CoV-2 vaccination in the first year after allogeneic hematopoietic cell transplant: A prospective, multicentre, observational study

JA Hill, P Westervelt - 2023 - digitalcommons.wustl.edu
Background The optimal timing for SARS-CoV-2 vaccines within the first year after
allogeneic hematopoietic cell transplant (HCT) is poorly understood. Methods We conducted …

SARS-CoV-2 vaccination in the first year after allogeneic hematopoietic cell transplant: a prospective, multicentre, observational study.

JA Hill, MJ Martens, JH Young, K Bhavsar, J Kou… - …, 2023 - europepmc.org
Background The optimal timing for SARS-CoV-2 vaccines within the first year after
allogeneic hematopoietic cell transplant (HCT) is poorly understood. Methods We conducted …